↓ Skip to main content

Schlafen 5 as a novel therapeutic target in pancreatic ductal adenocarcinoma

Overview of attention for article published in Oncogene, April 2021
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (70th percentile)
  • Good Attention Score compared to outputs of the same age and source (67th percentile)

Mentioned by

twitter
12 X users

Citations

dimensions_citation
9 Dimensions

Readers on

mendeley
3 Mendeley
Title
Schlafen 5 as a novel therapeutic target in pancreatic ductal adenocarcinoma
Published in
Oncogene, April 2021
DOI 10.1038/s41388-021-01761-1
Pubmed ID
Authors

Mariafausta Fischietti, Frank Eckerdt, Gavin T. Blyth, Ahmet D. Arslan, William M. Mati, Chidera V. Oku, Ricardo E. Perez, Catalina Lee-Chang, Ewa M. Kosciuczuk, Diana Saleiro, Elspeth M. Beauchamp, Maciej S. Lesniak, Daniela Verzella, Leyu Sun, Eleanor N. Fish, Guang-Yu Yang, Wenan Qiang, Leonidas C. Platanias

X Demographics

X Demographics

The data shown below were collected from the profiles of 12 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 3 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 3 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 1 33%
Professor > Associate Professor 1 33%
Student > Doctoral Student 1 33%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 1 33%
Agricultural and Biological Sciences 1 33%
Medicine and Dentistry 1 33%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 6. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 22 April 2021.
All research outputs
#6,236,570
of 24,974,461 outputs
Outputs from Oncogene
#3,811
of 11,039 outputs
Outputs of similar age
#127,853
of 433,913 outputs
Outputs of similar age from Oncogene
#40
of 123 outputs
Altmetric has tracked 24,974,461 research outputs across all sources so far. This one has received more attention than most of these and is in the 74th percentile.
So far Altmetric has tracked 11,039 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.4. This one has gotten more attention than average, scoring higher than 65% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 433,913 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 70% of its contemporaries.
We're also able to compare this research output to 123 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 67% of its contemporaries.